A recent study revealed that aberrant posttranslational modification of steroid receptors including ERα in T cells contributed to the gender-bias of SLE and that targeting ERα could improve the symptoms of lupus patients [266]. The gene discussed is ESR1; the disease is systemic lupus erythematosus.